BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10426897)

  • 1. T-cell receptor gene analysis in the diagnosis of Sézary syndrome.
    Russell-Jones R; Whittaker S
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):254-9. PubMed ID: 10426897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome.
    Fraser-Andrews EA; Russell-Jones R; Woolford AJ; Wolstencroft RA; Dean AJ; Whittaker SJ
    Cancer; 2001 Oct; 92(7):1745-52. PubMed ID: 11745245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
    Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
    Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome.
    Morice WG; Katzmann JA; Pittelkow MR; el-Azhary RA; Gibson LE; Hanson CA
    Am J Clin Pathol; 2006 Mar; 125(3):364-74. PubMed ID: 16613339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome.
    Whittaker SJ; Smith NP; Jones RR; Luzzatto L
    Cancer; 1991 Oct; 68(7):1572-82. PubMed ID: 1654197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
    Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
    Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping.
    Bakels V; van Oostveen JW; Preesman AH; Meijer CJ; Willemze R
    J Clin Pathol; 1998 Feb; 51(2):154-8. PubMed ID: 9602691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood flow cytometry in Sézary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up.
    Novelli M; Fava P; Sarda C; Ponti R; Osella-Abate S; Savoia P; Bergallo M; Lisa F; Fierro MT; Quaglino P
    Am J Clin Pathol; 2015 Jan; 143(1):57-69. PubMed ID: 25511143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clonal nature of circulating Sezary cells.
    Weinberg JM; Jaworsky C; Benoit BM; Telegan B; Rook AH; Lessin SR
    Blood; 1995 Dec; 86(11):4257-62. PubMed ID: 7492785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.
    Nagler AR; Samimi S; Schaffer A; Vittorio CC; Kim EJ; Rook AH
    J Am Acad Dermatol; 2012 Mar; 66(3):503-8. PubMed ID: 22005074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome.
    Kelemen K; Guitart J; Kuzel TM; Goolsby CL; Peterson LC
    Am J Clin Pathol; 2008 Jan; 129(1):146-56. PubMed ID: 18089499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
    Klemke CD; Brade J; Weckesser S; Sachse MM; Booken N; Neumaier M; Goerdt S; Nebe TC
    Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
    Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
    Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.
    Rappl G; Muche JM; Abken H; Sterry W; Tilgen W; Ugurel S; Reinhold U
    J Am Acad Dermatol; 2001 Mar; 44(3):456-61. PubMed ID: 11209115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome.
    Foucar K
    Am J Clin Pathol; 2007 Apr; 127(4):496-510. PubMed ID: 17369126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.